Jazz Pharmaceuticals Public Limited Company (JAZZ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
128.52+1.16 (+0.91%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close127.36
Bid109.11 x 100
Ask138.00 x 500
Day's Range126.90 - 129.64
52wk Range108.50 - 173.79
1y Target EstN/A
Market Cap7.78B
P/E Ratio (ttm)22.59
Avg Vol (3m)782,796
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Benzinga14 hours ago

    Here Are All The Big Biotech Mergers In 2016

    Biotech is one of the sectors where M&A activities never stop, as the potential for growth and development is immense. After the termination of a $160 billion merger with Allergan plc Ordinary Shares (NYSE: ...

  • Hedge Funds Are Obesely Overweight These 5 Mid-caps
    Insider Monkey2 days ago

    Hedge Funds Are Obesely Overweight These 5 Mid-caps

    Given the immense size of the broader market and the relatively small number of funds in our database (not to mention we don’t track many mutual funds or other gargantuan investment vehicles), the collection of funds that we track typically don’t have ownership of more than 20% of any given stock. In the instance of Herbalife Ltd. […]

  • Benzinga3 days ago

    Janney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy Franchise'

    Janney started coverage of Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: JAZZ ) with a Neutral rating, citing potential competition to its blockbuster narcolepsy franchise. Jazz's history was based ...